Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003492
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Who this might be right for
Stage IV Lung Cancer
Burzynski Research Institute 9
Not applicableUnknownNCT02555592
What this trial is testing

Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level

Who this might be right for
Lung CancerCancer of Lymph NodeEffects of Chemotherapy+1 more
Pusan National University Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04077099
What this trial is testing

REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Regeneron Pharmaceuticals 95
Testing effectiveness (Phase 2)Looking for participantsNCT06656598
What this trial is testing

Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Who this might be right for
Stage III NSCLC
Intergroupe Francophone de Cancerologie Thoracique 152
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03382795
What this trial is testing

Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients

Who this might be right for
EGFR Positive Non-small Cell Lung Cancer
Korea University Guro Hospital 63
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Large-scale testing (Phase 3)Study completedNCT03150875
What this trial is testing

A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 290
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)Study completedNCT00745875
What this trial is testing

ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study

Who this might be right for
Non Small Cell Lung CancerLung Cancer
AstraZeneca 66
Testing effectiveness (Phase 2)Study completedNCT00723957
What this trial is testing

Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer
R-Pharm 260
Not applicableNo Longer AvailableNCT02271139
What this trial is testing

Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc.
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Early research (Phase 1)Study completedNCT00004930
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01783834
What this trial is testing

Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients

Who this might be right for
Previous Treated Metastatic Non-small Cell Lung Cancer
Gachon University Gil Medical Center 95
Testing effectiveness (Phase 2)WithdrawnNCT04158700
What this trial is testing

LY3200882 and Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT00452244
What this trial is testing

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
National Cancer Center, Korea 110
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Testing effectiveness (Phase 2)Study completedNCT03801304
What this trial is testing

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Brest 80
Not applicableEnded earlyNCT00769652
What this trial is testing

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Who this might be right for
Lung CancerMalnutritionPancreatic Cancer+2 more
Rutgers, The State University of New Jersey 8
Next Page